TY - JOUR
T1 - Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome
AU - Perea, José
AU - Rodríguez, Yolanda
AU - Rueda, Daniel
AU - Marín, Jose C.
AU - Díaz-Tasende, José
AU - Álvaro, Edurne
AU - Alegre, Cristina
AU - Osorio, Irene
AU - Colina, Francisco
AU - Lomas, Manuel
AU - Hidalgo, Manuel
AU - Benítez, Javier
AU - Urioste, Miguel
N1 - Funding Information:
ACKNOWLEDGMENT This work was funded by the Mutua Madrileña Foundation (Project P133-08). The authors thank the Pathology Departments of Gregorio Marañón University Hospital, Segovia Hospital, and 12 de Octubre University Hospital for providing us with the paraffin-embedded tissues, and Ron Hartong for his help with the English redaction of the article.
PY - 2011/11
Y1 - 2011/11
N2 - Background and Objectives. Early age of onset is a marker of a possible hereditary component in colorectal cancer (CRC). We evaluated whether early age of onset is a good marker to identify Lynch syndrome, especially retrospectively, and if there is any other feature that could improve this identification. Methods: We selected patients with CRC aged 45 years or younger from the pathological reports of three different institutions and different periods of time. Clinical information, family history, and tumor samples were obtained. Cases were classified according to mismatch repair (MMR) proficiency. Results: Of 133 tumors, 22 showed microsatellite instability (MSI). In 15 MSI cases, a germline mutation in 1 of the MMR genes was identified, 7 of which were not identified before. The positive predictive value (PPV) of right colon CRC for a positive genetic MMR test is 30.6%, whereas "signet ring" cells and fulfillment Amsterdam II criteria have PPVs of 42.9% and 47.8%, respectively. Combining right-sided CRC with mucin production, with fulfilling Amsterdam II criteria, or with "signet ring" cells, PPVs are 54.5, 64.3, and 100%. The probability of the absence of a mutation when CRC is located in the left colon is 94.7%, whereas absence of aggregation for Lynchrelated neoplasm has a 100% probability. Conclusions: Early age of onset is an effective method to identify retrospectively Lynch syndrome. Taking into account the location and histology features of the tumor, and the familial history of the cases, we notably increase the a priori probability of detecting a germline MMR mutation.
AB - Background and Objectives. Early age of onset is a marker of a possible hereditary component in colorectal cancer (CRC). We evaluated whether early age of onset is a good marker to identify Lynch syndrome, especially retrospectively, and if there is any other feature that could improve this identification. Methods: We selected patients with CRC aged 45 years or younger from the pathological reports of three different institutions and different periods of time. Clinical information, family history, and tumor samples were obtained. Cases were classified according to mismatch repair (MMR) proficiency. Results: Of 133 tumors, 22 showed microsatellite instability (MSI). In 15 MSI cases, a germline mutation in 1 of the MMR genes was identified, 7 of which were not identified before. The positive predictive value (PPV) of right colon CRC for a positive genetic MMR test is 30.6%, whereas "signet ring" cells and fulfillment Amsterdam II criteria have PPVs of 42.9% and 47.8%, respectively. Combining right-sided CRC with mucin production, with fulfilling Amsterdam II criteria, or with "signet ring" cells, PPVs are 54.5, 64.3, and 100%. The probability of the absence of a mutation when CRC is located in the left colon is 94.7%, whereas absence of aggregation for Lynchrelated neoplasm has a 100% probability. Conclusions: Early age of onset is an effective method to identify retrospectively Lynch syndrome. Taking into account the location and histology features of the tumor, and the familial history of the cases, we notably increase the a priori probability of detecting a germline MMR mutation.
UR - http://www.scopus.com/inward/record.url?scp=83055173132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83055173132&partnerID=8YFLogxK
U2 - 10.1245/s10434-011-1782-4
DO - 10.1245/s10434-011-1782-4
M3 - Article
C2 - 21590452
AN - SCOPUS:83055173132
SN - 1068-9265
VL - 18
SP - 3285
EP - 3291
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 12
ER -